AUTM on the Air

38:16

D. Max Crowley - What if Universities Have Built the...

AUTM on the Air ·

2026/09/30

Technology transfer offices usually keep score with patents, licenses, startups and revenue. It's real proof research is moving beyond the lab. Yet it can miss some of the most interesting parts of the story. A technology might reshape clinical practice, influence public policy or strengthen a community without ever producing a commercial outcome that fits neatly into an annual report. As tech transfer evolves, there's a growing opportunity to look past the traditional scorecard and ask how

en

56:21

Feel Your Best Self with Dr. Sandy Chafouleas, Emily...

AUTM on the Air ·

2026/09/23

Some of the most impactful innovations don’t fit neatly into the traditional technology transfer model. Feel Your Best Self began during the COVID-19 pandemic as a collaboration between educational psychology and puppetry at the University of Connecticut, with a simple goal: give children practical, research-based ways to understand and cope with big feelings. What started in a single classroom has since grown into an award-winning toolkit reaching families, educators, and communities far beyond

en

60:07

Why Global Capital is Betting on University Research...

AUTM on the Air ·

2026/09/16

University research can produce ideas with enormous potential, but turning those discoveries into something that reaches the market is rarely straightforward. Funding is part of the equation, but so are timing, evidence, relationships, and the ability to connect promising technologies with the right partners. As research and investment become increasingly global, universities are also looking beyond their own regions and countries for the capital, expertise, and opportunities needed to move

en

37:28

Michael Coyle - Drug Repurposing and Repositioning SIG

AUTM on the Air ·

2026/09/09

Drug repurposing and reformulation can open new possibilities for therapies that already exist, but these projects come with commercialization challenges that can look very different from traditional drug development. Questions around patent protection, regulatory pathways, market exclusivity, and industry interest can all affect whether a promising opportunity ever makes it out of the university.Helping us explore this unique area of tech transfer is Michael Coyle, a licensing officer at Vanderbilt

en

51:40

A National Treasure: How UAB’s Moon Nahm...

AUTM on the Air ·

2026/09/02

Pneumococcal disease remains a serious global health threat, particularly for young children, older adults, and people with weakened immune systems. Developing effective vaccines has never been simple. The bacterium can produce roughly 100 different serotypes, each protected by its own sugar capsule, which means immunity against one strain may offer little protection against another. In this episode, we look at the science that changed how these vaccines are tested and the technology transfer

en

48:45

PanCystPro™ and Early Pancreatic Cancer Detection...

AUTM on the Air ·

2026/08/26

Pancreatic cancer remains one of the most difficult cancers to detect early, and that challenge leaves clinicians and patients facing uncertainty when pancreatic cysts are discovered during imaging for other health concerns. In this episode of AUTM on the Air, we look at how a discovery from a Purdue University lab became the foundation for PanCystPro™, a diagnostic test developed by Amplified Sciences to help clinicians better distinguish between benign pancreatic cysts and those that may carry a

en

48:11

A New Golden Age — What the White House’s Research...

AUTM on the Air ·

2026/08/19

The way the federal government supports scientific research could be headed for a significant shift. A new White House report, *Science: A New Golden Age*, lays out a different vision for federal research funding—one that places less emphasis on the traditional university-centered grant model and more on mission-driven research, commercialization, and fields such as AI, quantum science, fusion, semiconductors, space, and robotics. For universities and technology transfer offices, those changes raise

en

52:04

Patents, Plant Variety Protection, CRISPR, and What...

AUTM on the Air ·

2026/08/12

Plant discoveries can be some of the trickiest inventions for a technology transfer office to manage. A new variety may come out of years of breeding work, field trials, university research, or newer tools like CRISPR, but the protection strategy is not always obvious. Depending on the plant, the market, and how it will be commercialized, a TTO may need to think about utility patents, plant patents, Plant Variety Protection certificates, contracts, international rights, and the practical realities

en

26:54

Collective Behavior, Decentralized Systems, and...

AUTM on the Air ·

2026/08/05

It might seem like a leap to connect ant colonies with technology transfer, but the connection is closer than it sounds. Ant colonies operate without a boss, a formal plan, or anyone directing traffic, yet they still find food, protect the colony, respond to threats, and adjust when conditions change. For anyone working in research commercialization, where progress often depends on many people and institutions moving in the same direction without anyone controlling the whole system, that’s a

en

43:40

Training the Next Generation of Innovation Leaders...

AUTM on the Air ·

2026/07/29

Training the next generation of technology transfer and commercialization leaders requires more than exposure to the field. It also means helping researchers think earlier about the real-world impact of their work, the communities they hope to serve, and the pathways that can move an idea beyond the university. At the University of Kentucky, Kendra Hargis-Stenzel has built practical, structured programs designed to bring those pieces together.Kendra is the Director of Innovation Talent Development

en

41:59

Advancing Biopharma Innovation with Ruben Flores-Saaib

AUTM on the Air ·

2026/07/22

Biopharma commercialization has always required more than a promising discovery. It takes the right team, the right timing, and often, the right kind of capital to move an idea from the university lab toward patients. My guest is Ruben Flores-Saaib, PhD, Senior Director of Investments and Business Development at Ligand Pharmaceuticals, a publicly traded biopharma company with a broad portfolio of partnered programs and approved medications. Ruben brings a rare perspective to this conversation

en

77:44

World Intellectual Property Report 2026: Technology...

AUTM on the Air ·

2026/07/15

A breakthrough can happen in one lab, but its real value depends on what happens next. How does a new technology move beyond its point of origin, reach the people and industries that can use it, and eventually become part of everyday life? The World Intellectual Property Organization’s “World Intellectual Property Report 2026: Technology on the Move” takes a wide-ranging look at those questions, drawing on 250 years of technological history and five decades of patent data to explore why some

en

48:15

Why Communication Matters in IP Strategy with Stephen...

AUTM on the Air ·

2026/07/08

University IP strategy can look straightforward from the outside. Protect the invention, manage the policy, move the technology toward the market. But anyone working inside a tech transfer office knows the process is rarely that simple. Faculty inventors, licensing teams, university leaders, outside counsel, and industry partners may all be working toward the same broad goal, but they often come into the conversation with very different expectations. That is where communication becomes more than a

en

31:02

How Venture Philanthropy Helps Move Rare Disease...

AUTM on the Air ·

2026/07/01

Getting discoveries out of the lab is only part of the commercialization journey. At some point, a promising idea reaches the stage where investment decisions can determine whether the science moves forward, stalls out, or becomes something that can truly reach patients. That moment is especially important in rare diseases, where the path to market can be long, complex, and difficult for traditional capital to support.My guest today is Tim Brent, Venture Principal with Pathway to Cures, the venture

en

27:24

How Thermo Fisher Evaluates University Innovation...

AUTM on the Air ·

2026/06/24

Industry partnerships can look very different depending on which side of the table you’re sitting on. For technology transfer professionals, the work often centers on preparing the opportunity, supporting the inventor, protecting the IP, and finding the right commercial partner. For companies like Thermo Fisher Scientific, the question is slightly different: does this technology solve a real problem, fit an existing product area, improve on something already in the market, or open the door to a new

en

48:26

Royalty Stacks: Turning Tech Transfer Into a Strategy...

AUTM on the Air ·

2026/06/17

Technology transfer is often described through patents, licenses, startups, and commercialization strategy, but rarely through the lens of a board game. In this episode of AUTM on the Air, we talk with Guru Venkatesan, a business development manager at Fred Hutch and the creator of Royalty Stacks, a tech-transfer-inspired game built around patents, licenses, and leverage. The game gives players a chance to take ideas, decide how broadly to protect them, and choose whether to bring them to market

en

26:39

How Novartis Approaches External Research...

AUTM on the Air ·

2026/06/10

University-industry partnerships often sound straightforward from the outside. A promising discovery is made, a company sees potential, and a collaboration begins. But anyone who has worked inside these agreements knows the reality is far more complex. Research goals, publication timelines, IP rights, background technology, data sources, and internal review processes all have to be understood before a partnership can move forward in a productive way.My guest today is Dr. Yogesh Sharma, Global Head

en

29:22

Bridging the Early-Stage Funding Gap in Innovation...

AUTM on the Air ·

2026/06/03

There’s a stretch of time in innovation where things feel the most uncertain, when the science is promising but the path forward isn’t clear and the capital hasn’t quite caught up. It’s a space that can quietly stall even the most compelling ideas. In this episode, the conversation zeroes in on that early stage gap and what it really takes to move something forward when the usual funding sources aren’t ready yet.My guest today is Teri Willey, founding managing director of Pathway to Cures, the

en

22:53

Detecting Alzheimer’s Earlier with a Simple Blood...

AUTM on the Air ·

2026/05/27

Early detection is everything when it comes to Alzheimer’s, but for years, the tools available have made that nearly impossible at scale. Today’s conversation takes a closer look at a breakthrough that could change that equation in a very real way. My guest is Dr. Yuanbing Jiang, also known as Jason, a research assistant professor in the Division of Life Science at the Hong Kong University of Science and Technology. His work sits at the intersection of neuroscience, proteomics, and large-scale data

en

24:12

Turning Research into Real World Impact from the...

AUTM on the Air ·

2026/05/20

Most people focus on the breakthrough, but there is a massive gap between a scientific discovery and a product that actually reaches the public. Today, we’re stepping into the "engine room" of one of Africa’s premier research institutions to see how that gap is bridged. My guest is Ravini Moodley, Director of the Technology Transfer Office at Stellenbosch University’s Innovus. She has a background in microbiology and a Master’s in Technology and Innovation Management. She also has the

en

All Episodes

Similar Podcasts

Lead With AI

Tamara Nall

Elon Musk Podcast

Stage Zero

Modem Futura

Sean Leahy, Andrew Maynard

Cisco Podcast Network

Cisco

MSP Business School

MSP Business School